Rheumatic Manifestations of Human Immunodeficiency Virus Infection

Infectious Disease Clinics of North America

Volumn 20, Issue 4, 2006, Pages 891-912

  Medina, Francisco ^a   Pérez Saleme, Leticia ^a   Moreno, José ^a  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIRETROVIRUS AGENT; CLARITHROMYCIN; ETANERCEPT; ETHAMBUTOL; FLUCONAZOLE; FLUCYTOSINE; HYDROXYCHLOROQUINE; INDOMETACIN; MACROLIDE; PROTEINASE INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFABUTIN; SALAZOSULFAPYRIDINE; STEROID; THALIDOMIDE; ZIDOVUDINE;

ARTHRALGIA; BACTERIAL INFECTION; BONE NECROSIS; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; DISEASE PREDISPOSITION; FIBROMYALGIA; GOUT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; HYPOTHYROIDISM; INFECTION CONTROL; INFECTION PREVENTION; INFECTIOUS ARTHRITIS; INSULIN RESISTANCE; LIFE EXPECTANCY; LIPODYSTROPHY; MYALGIA; MYCOSIS; NEOPLASM; OSTEOARTHROPATHY; OSTEOPOROSIS; PYOMYOSITIS; REACTIVE ARTHRITIS; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SURVIVAL RATE; TUBERCULOSIS;

ANIMALS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; AUTOIMMUNE DISEASES; FEMALE; HIV INFECTIONS; HUMANS; MALE; PREVALENCE; RHEUMATIC DISEASES; RISK FACTORS;

EID: 33751020557     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2006.09.002     Document Type: Review

References (156)

1. Merson M.H. The HIV-AIDS pandemic at 25: the global response. N Engl J Med 354 (2006) 2414-2416
2. Epidemic Update December AIDS. 2005. UNAIDS/ WHO ISBN 92 9 173439 X. Available at: http://www.who.int/hiv/epiupdates/en/index.html. Accessed August 18, 2006.
3. Understanding the latest estimates of the 2006 report on the global AIDS epidemic. Available at: http://www.who.int/hiv/epiupdates/en. Accessed August 18, 2006.
4. Vassilopoulos D., and Calabrese L.H. Rheumatologic manifestations of HIV-1 and HTLV-1 infections. Cleve Clin J Med 65 (1998) 436-441
5. Berman A., Cahn P., Perez H., et al. Prevalence and characteristics of rheumatic manifestations in patients infected with human immunodeficiency virus undergoing antiretroviral therapy. J Rheumatol 24 (1997) 2492
6. Cuellar M.L., and Espinoza L.R. Rheumatic manifestations of HIV-AIDS. Baillieres Best Pract Res Clin Rheumatol 14 (2000) 579-593
7. Buskila D., Gladman D.D., Langevitz P., et al. Rheumatologic manifestations of infection with the human immunodeficiency virus (HIV). Clin Exp Rheumatol 8 (1990) 567-573
8. Simms R.W., Zerbini C.A., Ferrante N., et al. Fibromyalgia syndrome in patients infected with human immunodeficiency virus. Am J Med 92 (1992) 368-374
9. Jeandel P., Chouc P.Y., and Laroche R. Rheumatological aspects of infection with human immunodeficiency virus. Med Trop (Mars) 50 (1990) 231-235
10. Sikdar S., Grover C., Kubba S., et al. An uncommon cause of scleroderma. Scand J Rheumatol 34 (2005) 242-245
11. Berman A., Cahn P., Perez H., et al. Human immunodeficiency virus infection associated arthritis: clinical characteristics. J Rheumatol 26 (1999) 1158-1162
12. Berman A., Espinoza L.R., Díaz J.D., et al. Rheumatic manifestations of human immunodeficiency virus infection. Am J Med 85 (1988) 59-64
13. Buskila D., and Gladman D. Musculoskeletal manifestations of infection with human immunodeficiency virus. Rev Infect Dis 12 (1990) 223-235
14. Hacbarth E.T., Freire C.A., and Atra E. Rheumatic manifestations of acquired immunodeficiency syndrome (AIDS). Rev Assoc Med Bras 38 (1992) 90-94
15. Medina-Rodriguez F., Guzman C., Jara L.J., et al. Rheumatic manifestations in human immunodeficiency virus positive and negative individuals: a study of 2 populations with similar risk factors. J Rheumatol 20 (1993) 1880-1884
16. Weeratunge C.N., Roldan J., and Anstead G.M. Jaccoud arthropathy: a rarity in the spectrum of HIV-associated arthropathy. Am J Med Sci 328 (2004) 351-353
17. Berman A., Reboredo G., Spindler A., et al. Rheumatic manifestations in populations at risk for HIV infection: the added effect of HIV. J Rheumatol 18 (1991) 1564-1567
18. Brantus J.F., and Meunier P.J. Rheumatic manifestations associated with human immunodeficiency virus infection. Rev Rhum Mal Osteoartic 59 (1992) 428-435
19. Calabrese L.H. Rheumatic manifestations of HIV infection. Cleve Clin J Med 60 (1993) 484-485
20. Espinoza L.R., Jara L.J., Espinoza C.G., et al. There is an association between human immunodeficiency virus infection and spondyloarthropathies. Rheum Dis Clin North Am 18 (1992) 257-266
21. Rivera J., and Garcia-Monforte A. Human immunodeficiency virus infection and arthritis. J Rheumatol 27 (2000) 1322-1323
22. Carreño Perez L. Septic arthritis. Baillieres Best Pract Res Clin Rheumatol 13 (1999) 37-58
23. Brantus J.F., and Meunier P.J. Rheumatic manifestations associated with human immunodeficiency virus infection. Rev Rhum Mal Osteoartic 59 (1992) 428-435
24. Njobvu P., McGill P., Kerr H., et al. Spondyloarthropathy and human immunodeficiency virus infection in Zambia. J Rheumatol 25 (1998) 1553-1559
25. Njobvu P., and McGill P. Human immunodeficiency virus related reactive arthritis in Zambia. J Rheumatol 32 (2005) 1299-1304
26. Adebajo A., and Davis P. Rheumatic diseases in African blacks. Semin Arthritis Rheum 24 (1994) 139-153
27. Cuellar M.L., and Espinoza L.R. Human immunodeficiency virus associated spondyloarthropathy: lessons from the Third World. J Rheumatol 26 (1999) 2071-2073
28. Chinniah K., Mody G.M., Bhimma R., et al. Arthritis in association with human immunodeficiency virus infection in black African children: causal or coincidental?. Rheumatology (Oxford) 44 (2005) 915-920
29. Keat A., and Rowe I. Reiter's syndrome and associated arthritides. Rheum Dis Clin North Am 17 (1991) 25-42
30. Saveuse H., Rouveix E., de Bandt M., et al. HLA-B27 inflammatory spondyloarthropathy, psoriasis and HIV infection. Presse Med 17 (1988) 698-699
31. De Bandt M., Saveuse H., Rouveix E., et al. Joint manifestations and HIV infections. Ann Med Interne (Paris) 139 (1988) 516-522
32. McGonagle D., Reade S., Marzo-Ortega H., et al. Human immunodeficiency virus associated spondyloarthropathy: pathogenic insights based on imaging findings and response to highly active antiretroviral treatment. Ann Rheum Dis 60 (2001) 696-698
33. Forster S.M., Seifert M.H., Keat A.C., et al. Inflammatory joint disease and human immunodeficiency virus infection. BMJ 296 (1988) 1625-1627
34. Altman E.M., Centeno L.V., Mahal M., et al. AIDS-associated Reiter's syndrome. Ann Allergy 72 (1994) 307-316
35. Calabrese L.H., O'Connell M., Kelley D.M., et al. A longitudinal study of patients infected with the human immunodeficiency virus (HIV). The influence of rheumatic symptoms on the natural history of retroviral infections. Arthritis Rheum 34 (1991) 257-263
36. Iwakura Y., Tosu M., Yoshida E., et al. Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-1. Science 253 (1991) 1026-1028
37. Medina F., Jara L.J., Miranda J.M., et al. Successful outcome in HIV+ patients with Reiter's syndrome treated with bromocriptine. Arthritis Rheum 36 (1993) 727-728
38. Buskila D., Langevitz P., Tenenbaum J., et al. Malar rash in a patient with Reiter's syndrome: a clue for the diagnosis of human immunodeficiency virus infection. J Rheumatol 17 (1990) 843-845
39. Blanche P. Acitretin and AIDS-related Reiter's disease. Clin Exp Rheumatol 17 (1999) 105-106
40. Lassoued S., Lassoued K., Marchou B., et al. Course of ankylosing spondylitis (AS) in patients with human immunodeficiency virus (HIV). J Rheumatol 18 (1991) 1939-1940
41. Mijiyawa M. Spondyloarthropathies in patients attending the rheumatology unit of Lome Hospital. J Rheumatol 20 (1993) 1167-1169
42. Mijiyawa M., Oniankitan O., Kolani B., et al. Low back pain in hospital outpatients in Lome (Togo). Joint Bone Spine 67 (2000) 533-538
43. Mijiyawa M., Grunitzky K., Agbanouvi E.A., et al. Spondyloarthritis in Togolese patients. Ann Med Interne (Paris) 142 (1991) 582-586
44. Sipsas N.V., Panayiotakopoulos G.D., Zormpala A., et al. HIV infection and ankylosing spondylitis. Which benefits from the coexistence?. Clin Rheumatol 19 (2000) 512
45. Mijiyawa M., Oniankitan O., and Khan M.A. Spondyloarthropathies in sub-Saharan Africa. Curr Opin Rheumatol 12 (2000) 281-286
46. Espinoza L.R., Berman A., Vasey F.B., et al. Psoriatic arthritis and acquired immunodeficiency syndrome. Arthritis Rheum 31 (1988) 1034-1040
47. Arnett F.C., Reveille J.D., and Duvic M. Psoriasis and psoriatic arthritis associated with human immunodeficiency virus infection. Rheum Dis Clin North Am 17 (1991) 59-78
48. Njobvu P., and McGill P. Psoriatic arthritis and human immunodeficiency virus infection in Zambia. J Rheumatol 27 (2000) 1699-1702
49. Schewe C.K., and Kellner H. Rapidly progressive seronegative spondylarthropathy with atlantodental subluxation in a patient with moderately advanced HIV infection. Clin Exp Rheumatol 14 (1996) 83-85
50. Pascual J.S., Balos L.L., and Baer A.N. Disseminated Prototheca wickerhamii infection with arthritis and tenosynovitis. J Rheumatol 31 (2004) 1861-1865
51. Belzunegui J., Rodriguez-Arrondo F., Gonzalez C., et al. Musculoskeletal infections in intravenous drug addicts: report of 34 cases with analysis of microbiological aspects and pathogenic mechanisms. Clin Exp Rheumatol 18 (2000) 383-386
52. Monteagudo I., Rivera J., Lopez-Longo J., et al. AIDS and rheumatic manifestations in patients addicted to drugs: an analysis of 106 cases. J Rheumatol 18 (1991) 1038-1041
53. Medina F., Hermida C., Jara L.J., et al. Staphylococcal arthritis in human immunodeficiency virus infection. Br J Rheumatol 34 (1995) 397-398
54. Barzilai A., Varon D., Martinowitz U., et al. Characteristics of septic arthritis in human immunodeficiency virus-infected haemophiliacs versus other risk groups. Rheumatology 38 (1999) 139-142
55. Tanaka S., Hachisuka K., Okazaki T., et al. Health status and satisfaction of asymptomatic HIV-positive haemophiliacs in Kyushu, Japan. Haemophilia 5 (1999) 56-62
56. Muñoz-Fernández S., Cardenal A., Balsa A., et al. Rheumatic manifestations in 556 patients with human immunodeficiency virus infection. Semin Arthritis Rheum 21 (1991) 30-39
57. Medina F., Jara L.J., Miranda J.M., et al. Artritis séptica: reporte de 65 casos. Rev Mex Rheumatol 10 (1995) 175-179
58. Casado E., Olive A., Holgado S., et al. Musculoskeletal manifestations in patients positive for human immunodeficiency virus: correlation with CD4 count. J Rheumatol 28 (2001) 802-804
59. Abouzahir A., Bouchama R., Azennag M., et al. Tropical pyomyositis simulating septic arthritis in AIDS patients. Two cases. Med Trop (Mars) 64 (2004) 372-374
60. Espinoza L.R., and Berman A. Soft tissues and osteo-articular infections in HIV-infected patients and other immunodeficient states. Baillieres Best Pract Res Clin Rheumatol 13 (1999) 115-128
61. Medina F., Fuentes M., Jara L.J., et al. Salmonella pyomyositis in patients with the human immunodeficiency virus. Br J Rheumatol 34 (1995) 568-571
62. Reginato A.J. Syphilitic arthritis and osteitis. Rheum Dis Clin North Am 19 (1993) 379-398
63. Solomon G., Brancato L., and Winchester R. An approach to the human immunodeficiency virus-positive patient with a spondyloarthropathic disease. Rheum Dis Clin North Am 17 (1991) 43-58
64. Chowdhry I.A., Tan I.J., Mian N., et al. Systemic lupus erythematosus presenting with features suggestive of human immunodeficiency virus infection. J Rheumatol 32 (2005) 1365-1368
65. Massabki P.S., Accetturi C., Nishie I.A., et al. Clinical implications of autoantibodies in HIV infection. AIDS 11 (1997) 1845-1850
66. Daikh B.E., and Holyst M.M. Lupus-specific autoantibodies in concomitant human immunodeficiency virus and systemic lupus erythematosus: case report and literature review. Semin Arthritis Rheum 30 (2001) 418-425
67. McNeil H.P., Chesterman C.N., and Krillis S.A. Immunology and clinical importance of antiphospholipids antibodies. Adv Immunol 49 (1991) 193-280
68. Rubbert A., Bock E., Schwab J., et al. Anticardiolipin antibodies in HIV infection: association with cerebral perfusion defects as detected by 99mTc-HMPAO SPECT. Clin Exp Immunol 98 (1994) 361-368
69. Authier F.J., and Gherardi R.K. Muscular complications of human immunodeficiency virus (HIV) infection in the era of effective anti-retroviral therapy. Rev Neurol (Paris) 162 (2006) 71-81
70. Calabrese L.H., and Naides S.J. Viral arthritis. Infect Dis Clin North Am 19 (2005) 963-980
71. Reinhardt R.L., Kang S.J., Liang H.E., et al. T helper cell effector fates - who, how and where?. Curr Opin Immunol 18 (2006) 271-277
72. Fontenot J.D., Rasmussen J.P., Williams L.M., et al. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22 (2005) 329-341
73. Seroude V., Audoly G., Gluschankof P., et al. Viral and cellular specificities of caprine arthritis encephalitis virus Vif protein. Virology 292 (2002) 156-161
74. Petkovic M., and Metlas R. Cross-reactivity of the V3-speciflc antibodies with the human C1q. Z Naturforsch [C] 56 (2001) 1135-1143
75. Bruhl H., Cihak J., Stangassinger M., et al. Depletion of CCR5-expressing cells with bispecific antibodies and chemokine toxins: a new strategy in the treatment of chronic inflammatory diseases and HIV. J Immunol 166 (2001) 2420-2426
76. Zapico I., Coto E., Rodriguez A., et al. CCR5 (chemokine receptor-5) DNA-polymorphism influences the severity of rheumatoid arthritis. Genes Immun 1 (2000) 288-289
77. Shieh B., Liau Y.E., Hsieh P.S., et al. Influence of nucleotide polymorphisms in the CCR2 gene and the CCR5 promoter on the expression of cell surface CCR5 and CXCR4. Int Immunol 12 (2000) 1311-1318
78. Itescu S. Diffuse infiltrative lymphocytosis syndrome in children and adults infected with HIV-1: a model of rheumatic illness caused by acquired viral infection. Am J Reprod Immunol 28 (1992) 247-250
79. Hansen A., Feist E., Hiepe F., et al. Diffuse infiltrative lymphocytosis syndrome in a patient with anti-52-kd Ro/SSA and human immunodeficiency virus type 1. Arthritis Rheum 42 (1999) 578-580
80. Weyand C.M., and Goronzy J.J. HIV infection and rheumatic diseases: autoimmune mechanisms in immunodeficient hosts. Z Rheumatol 51 (1992) 55-64
81. Fierabracci A., Upton C.P., Hajibagheri N., et al. Lack of detection of retroviral particles (HIAP-1) in the H9 T cell line co-cultured with thyrocytes of Graves' disease. J Autoimmun 16 (2001) 457-462
82. Sander D.M., Szabo S., and Gallaher W.R. Involvement of human intracisternal A-type retroviral particles in autoimmunity. Microsc Res Tech 68 (2005) 222-234
83. Obermayer-Straub P., and Manns M.P. Hepatitis C and D, retroviruses and autoimmune manifestations. J Autoimmun 16 (2001) 275-285
84. Stellbrink H.J., and van Lunzen J. Lymph node during antiretroviral treatment. Curr Opin Infect Dis 14 (2001) 17-22
85. Carr A., Samaras K., Burton S., et al. A syndrome of peripheral lipodystrophy, hyperlipidemia and insulin resistance in patients receiving HIV-protease inhibitors. AIDS 12 (1998) F51-F58
86. Behrens G., Schmidt H., Meyer D., et al. Vascular complications associated with use of HIV protease inhibitors. Lancet 351 (1998) 1958
87. Brooks J.I., Gallicano K., Garber G., et al. Acute monoarthritis complicating therapy with indinavir. AIDS 14 (2000) 2064-2065
88. Allroggen A., Frese A., Rahmann A., et al. HIV associated arthritis: case report and review of the literature. Eur J Med Res 10 (2005) 305-308
89. Florence E., Schrooten W., Verdont K., et al. Rheumatological complication associated with the use of indinavir and other protease inhibitors. Ann Rheum Dis 61 (2002) 82-84
90. Reveille J.D. The changing spectrum of rheumatic disease in human immunodeficiency virus infection. Semin Arthritis Rheum 30 (2000) 147-166
91. Paton N.I.J., Macallan D.C., Griffin G.E., et al. Bone mineral density in patients with human immunodeficiency virus infection. Calcif Tissue Int 61 (1997) 30-32
92. Tebas P., Powderly W.G., Claxton S., et al. Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS 10 (2000) F63-F67
93. Medina F., Pérez L., Sartorius C., et al. Osteoporosis in human immunodeficiency virus infected patients. Arthritis Rheum 43 (2000) S203
94. Blangy H., Loeuille D., Chary-Valckenaere I., et al. Osteonecrosis of the femoral head in HIV-1 patients: four additional cases. AIDS 14 (2000) 2214
95. Meyer D., Behrens G., Schmidt R.E., et al. Osteonecrosis of the femoral head in patients receiving HIV protease inhibitors. AIDS 13 (1999) 1147
96. Miller K.D., Masur H., Jones E.C., et al. High prevalence of osteonecrosis of the femoral head in HIV-infected adults. Ann Intern Med 137 (2002) 17-25
97. Kong Y.Y., and Penninger J.M. Molecular control of bone remodeling and osteoporosis. Exp Gerontol 35 (2000) 947-956
98. Creighton S., Miller R., Edwards S., et al. Is ritonavir boosting associated with gout?. Int J STD AIDS 16 (2005) 362-364
99. Khamashta M.A., and Hughes G.R.V. Antiphospholipid antibodies and antiphospholipid syndrome. Curr Opin Rheumatol 7 (1995) 389-394
100. Asherson R.A., and Shoenfeld Y. Human immunodeficiency virus infection, antiphospholipid antibodies, and the antiphospholipid syndrome. J Rheumatol 30 (2003) 214-219
101. Cervera R., Asherson R.A., Acevedo M.L., et al. Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients. Ann Rheum Dis 63 (2004) 1312-1317
102. Ramos-Casals M., Cervera R., Lagrutta M., et al. Clinical features related to antiphospholipid syndrome in patients with chronic viral infections (hepatitis C virus/HIV infection): description of 82 cases. Clin Infect Dis 38 (2004) 1009-1015
103. Jellis J.E. Bacterial infections: bone and joint tuberculosis. Baillieres Clin Rheumatol 9 (1995) 151-159
104. Friedmann R.J., and Stevanovic L. Chronic spondylogenic pain syndrome: TB-spondylitis?. Schweiz Rundsch Med Prax 83 (1994) 519-524
105. Pszolla N., Strecker W., Hartwig E., et al. Tuberculous spondylitis of the cervical spine. Unfallchirurg 103 (2000) 322-325
106. Mallolas J., Gatell J.M., Rovira M., et al. Vertebral arch tuberculosis in two human immunodeficiency virus-seropositive heroin addicts. Arch Intern Med 148 (1988) 1125-1127
107. Schinina V., Rizzi E.B., Rovighi L., et al. Infectious spondylodiscitis: magnetic resonance imaging in HIV-infected and HIV-uninfected patients. Clin Imaging 25 (2001) 362-367
108. Trapiella L., Caminal L., Bernaldo De Quiros J.I., et al. Poncet's disease in HIV infected patients. Med Clin (Barc) 117 (2001) 557
109. Leibert E., Schluger N.W., Bonk S., et al. Spinal tuberculosis in patients with human immunodeficiency virus infection: clinical presentation, therapy and outcome. Tuber Lung Dis 77 (1996) 329-334
110. Garcia-Lechuz J.M., Julve R., Alcala L., et al. Experience in a general hospital. Enferm Infecc Microbiol Clin 20 (2002) 5-9
111. Narlawar R.S., Shah J.R., Pimple M.K., et al. Isolated tuberculosis of posterior elements of spine: magnetic resonance imaging findings in 33 patients. Spine 27 (2002) 275-281
112. Pertuiset E., Beaudreuil J., Liote F., et al. Spinal tuberculosis in adults: a study of 103 cases in a developed country,1980-1994. Medicine (Baltimore) 78 (1999) 309-320
113. Whiteman M.L. Neuroimaging of central nervous system tuberculosis in HIV-infected patients. Neuroimaging Clin N Am 7 (1997) 199-214
114. Cotten A., Flipo R.M., Drouot M.H., et al. Spinal tuberculosis: study of clinical and radiological aspects from a series of 82 cases. J Radiol 77 (1996) 419-426
115. Villoria M.F., Fortea F., Moreno S., et al. MR imaging and CT of central nervous system tuberculosis in the patient with AIDS. Radiol Clin North Am 33 (1995) 805-820
116. Borges M.A., Carmo M.I., Sambo M.R., et al. Intramedullary tuberculoma in a patient with human immunodeficiency virus infection and disseminated multidrug-resistant tuberculosis: case report. Int J Infect Dis 2 (1998) 164-167
117. Casado-Burgos E., Muga-Bustamante R., Olive-Marques A., et al. Infectious arthritis by Mycobacterium kansasii in a patient with human immunodeficiency virus. Med Clin (Barc) 116 (2001) 237-238
118. Pintado V., Antela A., Corres J., et al. Arthritis and tenosynovitis caused by Mycobacterium kansasii associated with human immunodeficiency virus infection. Rev Clin Esp 199 (1999) 863
119. Hakawi A.M., and Alrajhi A.A. Septic arthritis due to Mycobacterium szulgai in a patient with human immunodeficiency virus: case report. Scand J Infect Dis 37 (2005) 235-237
120. Ollagnier E., Fresard A., Guglielminotti C., et al. Osteoarticular Mycobacterium xenopi infection. Presse Med 27 (1998) 800-803
121. Gioulekas J., and Hall A. Uveitis associated with rifabutin therapy. Aust N Z J Ophthalmol 23 (1995) 319-321
122. Govender S., Parbhoo A.H., Kumar K.P., et al. Anterior spinal decompression in HIV-positive patients with tuberculosis: a prospective study. J Bone Joint Surg Br 83 (2001) 864-867
123. Govender S., Annamalai K., Kumar K.P., et al. Spinal tuberculosis in HIV positive and negative patients: immunological response and clinical outcome. Int Orthop 24 (2000) 163-166
124. Leitao J., Govender S., and Parbhoo A.H. Pyogenic spondylitis. S Afr J Surg 37 (1999) 79-82
125. Touchard P., Chouc P.Y., Fulpin J., et al. HIV infection manifesting as a pneumococcal spondylodiscitis. Med Trop (Mars) 56 (1996) 275-278
126. Boix V., Tovar J., and Martin-Hidalgo A. Candida spondylodiscitis: chronic illness due to heroin analgesia in an HIV positive person. J Rheumatol 17 (1990) 563-565
127. Govender S., Mutasa E., and Parbhoo A.H. Cryptococcal osteomyelitis of the spine. J Bone Joint Surg Br 81 (1999) 459-461
128. + T cell homeostasis and function in advanced HIV disease. Science 277 (1997) 112-116
129. Lange C.G., and Lederman M.M. Immune reconstitution with antiretroviral therapies in chronic HIV-1 infection. J Antimicrob Chemother 51 (2003) 1-4
130. DeSimone J.A., Pomerantz R.J., and Babinchak T.J. Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Ann Intern Med 133 (2000) 447-454
131. Shelburne III S.A., Hamill R.J., Rodriguez-Barradas M.C., et al. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine 81 (2002) 213-227
132. French M.A., Price P., and Stone S.F. Immune restoration disease after antiretroviral therapy. AIDS 18 (2004) 1615-1627
133. Calabrese L.H., Kirchner E., and Shrestha R. Rheumatic complications of human immunodeficiency virus infection in the era of highly active antiretroviral therapy: emergence of a new syndrome of immune reconstitution and changing patterns of disease. Semin Arthritis Rheum 35 (2005) 166-174
134. Breton G., Adle-Biassette H., Therby A., et al. Immune reconstitution inflammatory syndrome in HIV-infected patients with disseminated histoplasmosis. AIDS 20 (2006) 119-121
135. Leidner R.S., and Aboulafia D.M. Recrudescent Kaposi's sarcoma after initiation of HAART: a manifestation of immune reconstitution syndrome. AIDS Patient Care STDS 19 (2005) 635-644
136. Wegrzyn J., Livrozet J.M., Touraine J.L., et al. Rheumatoid arthritis after 9 years of human immunodeficiency virus infection: possible contribution of tritherapy. J Rheumatol 29 (2002) 2232-2234
137. Diri E., Lipsky P.E., and Berggren R.E. Emergence of systemic lupus erythematosus after initiation of highly active antiretroviral therapy for human immunodeficiency virus infection. J Rheumatol 27 (2000) 2711-2714
138. Calza L., Manfredi R., Colangeli V., et al. Systemic and discoid lupus erythematosus in HIV-infected patients treated with highly active antiretroviral therapy. Int J STD AIDS 14 (2003) 356-359
139. Neumann S., Kreth F., Schubert S., et al. Reiter's syndrome as a manifestation of an immune reconstitution syndrome in an HIV-infected patient: successful treatment with doxycycline. Clin Infect Dis 36 (2003) 1628-1629
140. Wood C., and Harrington Jr. W. AIDS and associated malignancies. Cell Res 15 (2005) 947-952
141. Bower M., Palmieri C., and Dhillon T. AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy. Curr Opin Infect Dis 19 (2006) 14-19
142. Biviji A.A., Paiement G.D., and Steinbach L.S. Musculoskeletal manifestations of human immunodeficiency virus infection. J Am Acad Orthop Surg 10 (2002) 312-320
143. Peeva E., Davidson A., and Keiser H.D. Synovial non-Hodgkin's lymphoma in a human immunodeficiency virus infected patient. J Rheumatol 26 (1999) 696-698
144. Nyagol J., Leucci E., Onnis A., et al. The effects of HIV-1 Tat protein on cell cycle during cervical carcinogenesis. Cancer Biol Ther 5 (2006) 684-690
145. Grulich A.E., and Vajdic C.M. The epidemiology of non-Hodgkin lymphoma. Pathology 37 (2005) 409-419
146. Grabar S., Abraham B., Mahamat A., et al. Differential impact of combination antiretroviral therapy in preventing Kaposi's sarcoma with and without visceral involvement. J Clin Oncol 24 (2006) 3408-3414
147. Pantanowitz L., Schlecht H.P., and Dezube B.J. The growing problem of non-AIDS-defining malignancies in HIV. Curr Opin Oncol 18 (2006) 469-478
148. Itescu S. Rheumatic aspects of acquired immunodeficiency syndrome. Curr Opin Rheumatol 8 (1996) 346-353
149. Adebajo A.O., and Mijiyawa M. The role of sulphasalazine in African patients with HIV-associated seronegative arthritis. Clin Exp Rheumatol 16 (1998) 629
150. Chiang G., Sassaroli M., Louie M., et al. Inhibition of HIV-1 replication by hydroxychloroquine: mechanism of action and comparison with zidovudine. Clin Ther 18 (1996) 1080-1092
151. Combe B. Thalidomide: new indications?. J Bone Spine 68 (2001) 582-587
152. Neiger B.L. The re-emergence of thalidomide: results of a scientific conference. Teratology 62 (2000) 432-435
153. Settles B., Stevenson A., Wilson K., et al. Down-regulation of cell adhesion molecules LFA-1 and ICAM-1 after in vitro treatment with the anti-TNF-alpha agent thalidomide. Cell Mol Biol 47 (2001) 1105-1114
154. Traber K.E., Okamoto H., Kurono C., et al. Anti-rheumatic compound aurothioglucose inhibits tumor necrosis factor-alpha-induced HIV-1 replication in latently infected OM10.1 and Ach2 cells. Int Immunol 11 (1999) 143-150
155. Melaku Z., and Haga H.J. Rheumatological manifestations in HIV infections. Tidsskr Nor Laegeforen 120 (2000) 1326-1328
156. Aboulafia D.M., Bundow D., Wilske K., et al. Etanercept for the treatment of human immunodeficiency virus-associated psoriatic arthritis. Mayo Clin Proc 75 (2000) 1093-1098